✦ LIBER ✦

Congenital Myasthenic Syndromes in 2012

✍ Scribed by Andrew G. Engel

Publisher: Springer
Year: 2011
Tongue: English
Weight: 178 KB
Volume: 12
Category: Article
ISSN: 1528-4042
DOI: 10.1007/s11910-011-0234-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic Strategies in Congenital Mya

Therapeutic Strategies in Congenital Myasthenic Syndromes

✍ Ulrike Schara; Hanns Lochmüller 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 388 KB

The Therapy of Congenital Myasthenic Syn

The Therapy of Congenital Myasthenic Syndromes

✍ Andrew G. Engel 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 79 KB

Congenital myasthenic syndromes (CMSs) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more mechanisms. Specific diagnosis of a CMS is important as some medications that benefit one type of CMS can be detrimental in another type. In some

Congenital myasthenic syndromes: Progres

Congenital myasthenic syndromes: Progress over the past decade

✍ Andrew G. Engel; Kinji Ohno; Steven M. Sine 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

Congenital myasthenic syndrome with slee

Congenital myasthenic syndrome with sleep hypoventilation

✍ S.T. Iannaccone; J.K. Mills; K.M. Harris; J.H. Herman; P. Schochet; P. Luckett 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

What Have We Learned from the Congenital

What Have We Learned from the Congenital Myasthenic Syndromes

✍ Andrew G. Engel; Xin-Ming Shen; Duygu Selcen; Steven M. Sine 📂 Article 📅 2009 🏛 Humana Press Inc 🌐 English ⚖ 772 KB

A congenital myasthenic syndrome refract

A congenital myasthenic syndrome refractory to acetylcholinesterase inhibitors

✍ Dr. William J. Triggs; Dr. Aleksandar Beric; Dr. Ian J. Butler; Dr. Suresh M. Ro 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 753 KB

We studied 4 siblings (3 men and 1 woman), ages 22 to 43 years, with congenital ptosis, external ophthalmoplegia, proximal muscle weakness and fatigability unresponsive to acetylcholinesterase (AChE) inhibitors. Repetitive nerve stimulation showed a significant compound muscle action potential (CMAP